OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $78,000 | -7.1% | 16,300 | -4.7% | 0.00% | – |
| Q4 2016 | $84,000 | -5.6% | 17,100 | -4.5% | 0.00% | – |
| Q3 2016 | $89,000 | -9.2% | 17,900 | -7.3% | 0.00% | – |
| Q2 2016 | $98,000 | -14.0% | 19,300 | -3.5% | 0.00% | – |
| Q1 2016 | $114,000 | -48.4% | 20,000 | -6.1% | 0.00% | – |
| Q4 2015 | $221,000 | -43.8% | 21,300 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $393,000 | -5.1% | 21,300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $414,000 | +15.0% | 21,300 | 0.0% | 0.00% | – |
| Q1 2015 | $360,000 | 0.0% | 21,300 | 0.0% | 0.00% | – |
| Q4 2014 | $360,000 | +34.3% | 21,300 | 0.0% | 0.00% | – |
| Q3 2014 | $268,000 | -19.5% | 21,300 | 0.0% | 0.00% | – |
| Q2 2014 | $333,000 | +9.2% | 21,300 | 0.0% | 0.00% | – |
| Q1 2014 | $305,000 | -12.1% | 21,300 | 0.0% | 0.00% | – |
| Q4 2013 | $347,000 | -6.0% | 21,300 | -4.0% | 0.00% | -100.0% |
| Q3 2013 | $369,000 | +85.4% | 22,190 | +12.1% | 0.00% | – |
| Q2 2013 | $199,000 | – | 19,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,240,709 | $23,259,000 | 3.12% |
| PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $361,000 | 0.25% |
| Freedom Investment Management, Inc. | 118,284 | $1,228,000 | 0.09% |
| Spark Investment Management LLC | 62,800 | $651,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 98,901 | $1,027,000 | 0.05% |
| Baker Brothers Advisors | 499,193 | $5,182,000 | 0.04% |
| KILLEN GROUP INC | 31,000 | $322,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 127,263 | $1,321,000 | 0.02% |
| A.R.T. Advisors, LLC | 27,049 | $280,000 | 0.01% |
| QS Investors, LLC | 132,027 | $1,370,000 | 0.01% |